ライフサイエンスコーパス: hospital charge

1 charges were evaluated, along with the total hospital charge.

2 of stay; missed intra-abdominal injuries; or hospital charges.

3 a-abdominal injuries, ED length of stay, and hospital charges.

4 , discharge disposition, length of stay, and hospital charges.

5 ndary outcomes were length of stay and total hospital charges.

6 - 28,778.13 dollars) mean increase in total hospital charges.

7 ortality, hospital length of stay, and total hospital charges.

8 ccounted for 50% (>$31 million) of the total hospital charges.

9 h represents nearly a 50% reduction in total hospital charges.

10 antly the rate of unnecessary laparotomy and hospital charges.

11 gnificantly shorter hospital stays and lower hospital charges.

12 y, ventilator days, pneumonia, survival, and hospital charges.

13 on, incidence of GVHD, relapse, survival, or hospital charges.

14 of nosocomial pneumonia, length of stay, and hospital charges.

15 n-hospital stroke, length of stay, and total hospital charges.

16 patients' LOS, perioperative morbidity, and hospital charges.

17 ation, processes of care, length of stay and hospital charges.

18 had fewer complications and had lower total hospital charges.

19 4.9 days, corresponding to > or = $10 055 in hospital charges.

20 s, complications, in-hospital mortality, and hospital charges.

21 majority of ED visits, hospitalizations, and hospital charges.

22 therapeutic exploration, fetal outcomes, and hospital charges.

23 omplication rates, length of stay, and total hospital charges.

24 dicitis does not affect clinical outcomes or hospital charges.

25 on analysis was performed comparing LOS with hospital charges.

26 ive complications, length of stay, and total hospital charges.

27 acement, longest length of stay, and highest hospital charges.

28 of NAS and maternal opiate use, and related hospital charges.

29 ty, longer length of stay, and greater total hospital charges.

30 HAI also had significantly increased LOS and hospital charges.

31 ospital mortality, length of stay (LOS), and hospital charges.

32 078 dollars (99% CI, 8,300-9,855 dollars) in hospital charges.

33 ventilation or hospitalization but incurred hospital charges 1.5 times higher than controls (p = 0.0

34 wer (17.2% vs. 0%; P = 0.006), higher median hospital charges ($10,500 vs. $7200; P = 0.003), and a h

35 y rate (5.8% vs 8.3%; P < 0.05), and a lower hospital charge ($119,339 vs $138,496; P < 0.05).

36 significant differences were found for total hospital charges (139,207 US dollars vs. 148,190, adjust

37 dence interval, 1.03-1.62), and higher total hospital charges ($19,312; 95% confidence interval, 16,4

38 Hospital charges ($2011) increased 45.3%, driven by the

39 ency (length of stay, duration of procedure, hospital charges), 23 (59%) reported morbidity, and 6 (1

40 median, 2 versus 1 day; P<0.001), and higher hospital charges ($34 477 versus $14 921; P<0.001).

41 Since 2000, (1) price (especially of hospital charges [+4.2%/y], professional services [3.6%/

42 3 vs 4 days; P < .001), and lower mean total hospital charges ($40,387 vs $48,513; P < .001).

43 , P < 0.001) and had USD 36,291 higher total hospital charges (95% CI: USD 32,583-USD 40,000, P < 0.0

44 This was combined with hospital charges (a proxy for costs) to determine increm

45 in use was associated with greater inpatient hospital charges across all categories of fusion.

46 ifference: 0.89 days, P < 0.001), and higher hospital charges (adjusted mean difference: $13,257, P <

47 tal complications, length of stay, and total hospital charges, adjusting for case mix and hospital vo

48 nts (noninvasive or mechanical ventilation), hospital charges, admission rates, and hospital length o

49 hospital mortality rate, length of stay, and hospital charges, after adjusting for differences in cas

50 dentify a time point of change in mean total hospital charges among lung transplant and other solid-o

51 ars and older had an associated $9492 higher hospital charge and an increased 2(1/2)-day length of st

52 e; they accounted for 3.6 billion dollars in hospital charges and 1.4 billion dollars in Medicare rei

53 Data on hospital charges and cost-to-charge ratios for 64 hospit

54 Despite shorter hospital stays, in-hospital charges and costs for laparoscopically assisted

55 We studied hospital charges and costs for the procedure as compared

56 ect to impact on patient outcomes, including hospital charges and length of hospitalization.

57 In addition, hospital charges and lengths of stay were determined for

58 tracheostomy placement, length of stay, and hospital charges and payments adjusted by the medical co

59 Resource utilization (length of stay, hospital charges) and outcome (mortality) were compared.

60 e measures were in-hospital mortality, total hospital charge, and length of stay (LOS) for patients w

61 sociated with higher morbidity rates, higher hospital charges, and a higher risk of death than are at

62 recipient and donor serum creatinine levels, hospital charges, and complications.

63 patients had a shorter length of stay, lower hospital charges, and lower mortality rates than control

64 ngth of stay (LOS), mortality, readmissions, hospital charges, and Medicare payments.

65 visits, new patients, operative procedures, hospital charges, and physician charges.

66 ree days, fewer ventilator-free days, higher hospital charges, and reduced discharge home but also an

67 the following assumptions: (i) self-reported hospital charges are a good proxy for the opportunity co

68 estimate the increase in length of stay and hospital charge associated with complications.

69 In addition, the median hospital charges associated with primary admission and r

70 long with complications, length of stay, and hospital charges associated with use of this fusion adju

71 Hospital charges attributable to these admissions have g

72 ernia repair, length of hospitalization, and hospital charges based on the use of synthetic material

73 They also had lower total hospital charges, but the difference was not statistical

74 r hospital stay by 0.60 day (P=.003), higher hospital charges by $3732.71 (P=.02), and higher rate of

75 ter SPKT that were successful in stabilizing hospital charges by decreasing length of stay and clinic

76 onal estimates of hospitalizations and total hospital charges by year were calculated.

77 T group had longer length of stay and higher hospital charges compared with the anticoagulation group

78 ct patient outcomes, such as length of stay, hospital charges, complications, and mortality.

79 and employment status), hospital financials (hospital charges, costs, and financial class), and outco

80 The first approach was based on hospital charge data from complete hospital Universal Bi

81 Detailed in-hospital charge data were available from all 358 patient

82 By reviewing hospital charge data, patients who underwent elective co

83 fidence interval, 8-10), and increased total hospital charges (estimated mean increase of 22,000 US d

84 by POD 6, with corresponding mean transplant hospital charges (excluding organ acquisition) of $11,87

85 Median hospital charges (excluding rehabilitation), totaling $9

86 Length of stay decreased by 16% and mean hospital charges fell 5.2%.(Table is included in full-te

87 The mean hospital charge for MIP was less than 40% of that associ

88 Hospital charges for 9193 patients exceeded $164 million

89 r anterior cervical fusions and with greater hospital charges for all categories of fusions.

90 Adjusted mean hospital charges for complex fusion procedures were US $

91 Mean hospital charges for discharges with NAS increased from

92 n regional hospital market concentration and hospital charges for hepatopancreaticobiliary surgical p

93 In 2004, the national bill of hospital charges for hip/knee replacements was $26.0 bil

94 This has led to improved outcomes and lower hospital charges for patients with AC at this municipal

95 increased microbiology laboratory and total hospital charges for patients with bloodstream infection

96 The adjusted total hospital charges for patients with DD were $6678.78 high

97 of procedures and with decreased or similar hospital charges for resections and stents.

98 Consequently, total hospital charges for SPKT were no different in 1991 and

99 ays), days in hospital (over 60 days), total hospital charges for the index admission, and vital stat

100 m, time in the recovery room, complications, hospital charges for the operating room, and total hospi

101 hics, complication rate, length of stay, and hospital charges from 2000 through 2009.

102 readmission within 60 days of discharge, and hospital charges from initial postoperative hospitalizat

103 erative and postoperative records as well as hospital charges from the first 19 patients undergoing l

104 ion in diarrhea hospitalizations and related hospital charges has occurred among US children.

105 d hospitalizations in the United States, but hospital charges have increased substantially and are in

106 between the groups in surgical time or total hospital charges; however, the charge per informative fr

107 There was a 15% reduction in total hospital charge in the radial group.

108 f octreotide adds more than $75 to the daily hospital charge in the United States.

109 f hospital days, and 53.2% ($9.2 billion) of hospital charges in 2009.

110 ose of this study was to analyze and compare hospital charges in simultaneous pancreas-kidney transpl

111 the temporal trends in hospitalization rate, hospital charges, in-hospital mortality, length of hospi

112 atio, 1.36; 95% CI, 1.16-1.58; P < .001) and hospital charge (incidence rate ratio, 1.25; 95% CI, 1.0

113 Total transplant hospital charges increased by 40% in the post-LAS cohort

114 for CRT decreased, while mean CRT-associated hospital charges increased progressively over the years.

115 The hospital charges incurred by these patients was a median

116 f hospital and intensive care unit stay, and hospital charges incurred during the transplant admissio

117 Total hospital charge, length of stay, mortality, pneumonia, r

118 We compared differences in the hospital charges, length of hospital stay, and mortality

119 The main outcome measures were hospital charges, length of stay, and mortality among pa

120 Hospital charges, length of stay, readmissions, rejectio

121 sia appears to be safe, it comes with higher hospital charges, longer hospital stay, and a higher inc

122 Missing hospital charges (<5% of cases) were estimated using mul

123 study evaluating perioperative outcomes and hospital charge measures for distal pancreatectomy, comp

124 A significant point of increased total hospital charges occurred for lung transplant recipients

125 ions, linear regression demonstrated a daily hospital charge of $11,612 (R(2) = 0.923, R = 0.961).

126 this study was to evaluate the outcomes and hospital charges of liver transplantation during two rec

127 nt of reimbursement was $7.2 billion (28% of hospital charges or 79% of hospital cost).

128 was strongly associated with increased total hospital charges (P < 0.0001).

129 hospital (P <.01), (6) $25,405 in additional hospital charges (P <.0001), and (7) a 3.9-fold increase

130 However, the mean hospital charge per admission increased 2.7-fold from 20

131 Mean hospital charges per hospitalization increased 127% from

132 feeding by 6.4 weeks (P<0.001), and the mean hospital charges per patient by 88,600 dollars (in 2004

133 ersal Billing Code of 1992 forms, a detailed hospital charge questionnaire, or imputation.

134 transplants to Medicare were estimated from hospital charges, readmission rates, and immunosuppressa

135 ates with a shorter hospital stay and a mean hospital charge reduction of more than $4000 per case.

136 n the United States was observed, as well as hospital charges related to NAS.

137 Median hospital charges related to readmissions due to a surgic

138 01) and 30-day ($898 vs. $1,522, p = 0.0001) hospital charges than did patients given routine care.

139 nts had a longer hospitalization with higher hospital charges than the control group.

140 y decreased postoperative length of stay and hospital charges than the earlier ones.

141 inal hysterectomy was associated with higher hospital charges than the other techniques.

142 had a longer length of stay and higher mean hospital charges than white patients.

143 l stroke, a longer hospital stay, and higher hospital charges than whites.

144 Total hospital charge was also significantly lower in the radi

145 Mean hospital charges was $48.1K in both groups (P = 0.97).

146 ns, the optimal relationship between LOS and hospital charges was exponential (R(2) = 0.832).

147 Cost as represented by hospital charges was higher in the surgical group (mean,

148 relation between volume and hospital stay or hospital charges was observed only when the volume was a

149 The median total hospital charges were $1554 less for those who had open

150 Hospital charges were $282 lower, whereas Medicare costs

151 Median hospital charges were $29,057.00 higher for extubation d

152 h the invasive strategy, total mean (+/- SD) hospital charges were $3,436 lower per patient with PTCA

153 h of hospitalization was 22.2 days, the mean hospital charges were $358,200, and the mean inpatient c

154 Mean hospital charges were $42,749 higher among patients with

155 Median hospital charges were $46415 in the FAST group and $4775

156 Median hospital charges were $8,108 for laparoscopically assist

157 All hospital charges were adjusted for inflation to 2009 US

158 ition, the hospital length of stay and total hospital charges were also improved compared to conventi

159 Outcome and hospital charges were analyzed separately for recipients

160 al charges for the operating room, and total hospital charges were analyzed.

161 Hospital charges were available for 192 of the 279 nontr

162 tient characteristics, outcome measures, and hospital charges were compared for patients receiving al

163 Hospital charges were converted into costs by using cost

164 gth of stay was at least 10 days, and median hospital charges were elevated by at least $20 000 for i

165 Hospital charges were equivalent between the control gro

166 tients vs 5.0 for endovascular patients) and hospital charges were greater (mean, $38,000 for surgica

167 doses of narcotics, surgical difficultly and hospital charges were greater with the single site appro

168 dian length of stay was similar (6 days) and hospital charges were higher ($65 500 versus $75 870) at

169 All hospital charges were obtained.

170 Increases between 11% and 41% of total hospital charges were reported, with the greatest percen

171 toperative morbidity and mortality, LOS, and hospital charges were reviewed.

172 tal of 3,560 hospital days and $9,555,752 in hospital charges were saved over the period of the study

173 d mortality rates, length of stay, and total hospital charges were significantly higher for patients

174 Both average LOS and hospital charges were significantly increased among pati

175 operating room, operative charges, and total hospital charges were significantly reduced in the MIRP

176 Perioperative hospital charges were significantly related to LOS (R(2)

177 Lengths of hospital stay and hospital charges were similar between the two groups.

178 Mean operative times as well as total hospital charges were similar in those patients undergoi

179 The mean hospital charges were similar in those with vs without a

180 Hospital charges were slightly higher for CAS.

181 Length of stay and hospital charges were totaled for all hospitalizations,

182 Hospital charges were used as a proxy for hospital cost.

183 Hospital charges were used as a proxy for resource utili

184 near-fatal asthma-related events, had higher hospital charges, were more likely to be hospitalized, a

185 bed days, and 21.6% (US$17.7 billion) of all hospital charges within all hospitals.

186 ) of bed days and 29.0% (US$12.0 billion) of hospital charges within children's hospitals.

187 Total hospital charges, without correction for inflation, were